Difficulty: Medium
Average Score: 81%
Practice
Indication for dihydrotachysterol administration is:
Correct answer
A
Rationale
In this scenario, the correct answer is A) Parathyroid hormone resistance. Dihydrotachysterol is a synthetic form of vitamin D that is used to treat hypocalcemia in patients with parathyroid hormone resistance. This condition occurs when the body does not respond properly to parathyroid hormone, leading to low calcium levels. Dihydrotachysterol helps increase calcium absorption in the intestines and reabsorption in the kidneys, thereby addressing the underlying issue.
Option B) Paget's disease is incorrect because dihydrotachysterol is not indicated for this condition. Paget's disease is a bone disorder characterized by abnormal bone remodeling, and treatment typically involves bisphosphonates.
Option C) Increased osteolysis is also incorrect as dihydrotachysterol is not used to address increased breakdown of bone tissue. Instead, it focuses on improving calcium levels in cases of parathyroid hormone resistance.
Option D) Hypophosphatemia is not the correct answer because dihydrotachysterol is not primarily used to treat low phosphate levels. While vitamin D plays a role in phosphate regulation, dihydrotachysterol is more commonly associated with treating hypocalcemia related to parathyroid hormone resistance.
Educationally, understanding the specific indications for medications like dihydrotachysterol is crucial for healthcare professionals to make informed decisions in patient care. By knowing the appropriate uses of medications, healthcare providers can ensure safe and effective treatment strategies for their patients, ultimately improving patient outcomes.
Option B) Paget's disease is incorrect because dihydrotachysterol is not indicated for this condition. Paget's disease is a bone disorder characterized by abnormal bone remodeling, and treatment typically involves bisphosphonates.
Option C) Increased osteolysis is also incorrect as dihydrotachysterol is not used to address increased breakdown of bone tissue. Instead, it focuses on improving calcium levels in cases of parathyroid hormone resistance.
Option D) Hypophosphatemia is not the correct answer because dihydrotachysterol is not primarily used to treat low phosphate levels. While vitamin D plays a role in phosphate regulation, dihydrotachysterol is more commonly associated with treating hypocalcemia related to parathyroid hormone resistance.
Educationally, understanding the specific indications for medications like dihydrotachysterol is crucial for healthcare professionals to make informed decisions in patient care. By knowing the appropriate uses of medications, healthcare providers can ensure safe and effective treatment strategies for their patients, ultimately improving patient outcomes.